Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study

BACKGROUND: To conduct an economic evaluation comparing ranolazine as add-on therapy to standard-of-care (SoC) with SoC alone in patients with stable angina who did not respond adequately to first line therapy, in Greece. METHODS: A decision tree model was locally adapted in the Greek setting to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Kourlaba, Georgia, Vlachopoulos, Charalambos, Parissis, John, Kanakakis, John, Gourzoulidis, George, Maniadakis, Nikos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683812/
https://www.ncbi.nlm.nih.gov/pubmed/26684327
http://dx.doi.org/10.1186/s12913-015-1228-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683812/
https://www.ncbi.nlm.nih.gov/pubmed/26684327
http://dx.doi.org/10.1186/s12913-015-1228-y

Ejemplares similares